RxCelerate
Nick Tait is an experienced finance professional with a strong background in leading financial operations across various organizations. Currently serving as Group CFO at RXCELERATE LIMITED and Director at THE CAMBRIDGE PARTNERSHIP LIMITED since March 2018, Nick also holds a position as Non Executive Director at Cambridge Healthcare Research. Previous roles include Company Secretary at DefiniGEN, Associate Director at DeNovo Partners ltd, and Finance Director at Metrion Biosciences. Nick has also served as Chief Financial Officer at Ranier Technology Ltd and Financial Controller at Qype. With extensive experience in finance, administrative, and human resource matters, Nick Tait's expertise is complemented by a BSc in Economics from the University of Warwick.
This person is not in any teams
RxCelerate
1 followers
RxCelerate Limited is a leading outsourced drug development company based in Cambridge (U.K) delivering complete preclinical programmes to our clients. We offer a comprehensive suite of services under one roof, including in silico modelling, medicinal chemistry, in vitro and preclinical capabilities, and project management. We pride ourselves on our ability to deliver innovative cutting-edge experimental solutions that save our clients time and money. Our flexible approach, commitment to quality, and ability to deliver results quickly make us the perfect partner for unlocking the true potential of your drug development journey. We are not just a company; we are a people-first organisation. We invest in and value our employees and have created an environment that encourages collaboration, innovation and personal growth. We foster a culture of inclusivity, where every team member’s voice is heard, and their ideas are valued. Connect with us to be part of our exciting journey!